loading

Finanzdaten der Ideaya Biosciences Inc-Aktie (IDYA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- 7.00 - -
Operating Expenses
5.23%
88.81
84.39 151.14 66.89 64.93
Depreciation and Amortization
16.67%
0.70
0.60 0.60 0.60 0.60
Operating Income/Loss
5.23%
-88.81
-84.39 -144.14 -66.89 -64.93
Nonoperating Income/Loss
7.34%
11.31
12.21 13.83 15.07 12.15
Income/Loss From Continuing Operations Before Tax
7.36%
-77.49
-72.18 -130.31 -51.82 -52.77
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
7.36%
-77.49
-72.18 -130.31 -51.82 -52.77
Net Income/Loss
7.36%
-77.49
-72.18 -130.31 -51.82 -52.77
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.13%
88.47
88.36 1.9013 86.19 77.96
Diluted Average Shares
0.13%
88.47
88.36 1.9013 86.19 77.96
Basic Earnings Per Share
7.32%
-0.88
-0.82 -1.55 -0.60 -0.68
Diluted Earnings Per Share
7.32%
-0.88
-0.82 -1.55 -0.60 -0.68
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$83.69
price down icon 0.11%
$22.08
price up icon 2.69%
$32.13
price up icon 1.13%
$102.31
price up icon 0.35%
$164.72
price up icon 1.08%
biotechnology ONC
$328.88
price up icon 2.25%
Kapitalisierung:     |  Volumen (24h):